TrialPanorama/TrialPanorama-database huggingface dataset:
Study 25080540 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 25080540 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study 25081818 — Predictive Biomarker (PRD): ST8SIA4 mRNA
Genes: ST8SIA4; PST; PST1; SIAT8D
Study 25082885 — Predictive Biomarker (PRD): BEST1 mRNA
Genes: BEST1; VMD2
Study 25082885 — Predictive Biomarker (PRD): EFEMP1 mRNA
Genes: EFEMP1; FBLN3; FBNL
Study 25082885 — Predictive Biomarker (PRD): TIMP3 mRNA
Genes: TIMP3
Study 25082885 — Predictive Biomarker (PRD): PRPH2 mRNA
Genes: PRPH2; PRPH; RDS; TSPAN22
Study 25082885 — Predictive Biomarker (PRD): ELOVL4 mRNA
Genes: ELOVL4
Study 25082885 — Predictive Biomarker (PRD): ABCA4 mRNA
Genes: ABCA4; ABCR
Study 25085007 — Predictive Biomarker (PRD): CP mRNA
Genes: CP
Study 25085119 — Predictive Biomarker (PRD): FMOD mRNA
Genes: FMOD; FM; SLRR2E
Study 25085632 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor receptor 2
Genes: KDR; FLK1; VEGFR2
Study 25085632 — Predictive Biomarker (PRD): RET mRNA
Genes: RET; CDHF12; CDHR16; PTC; RET51
Study 25091095 — Pharmacodynamic Biomarker (PDY): Tyrosine-protein kinase BTK
Genes: BTK; AGMX1; ATK; BPK
Study 25091263 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study 25091263 — Predictive Biomarker (PRD): KRAS mRNA
Genes: KRAS; KRAS2; RASK2
Study 25091629 — Predictive Biomarker (PRD): SI mRNA
Genes: SI
Study 25091629 — Safety Biomarker (SAF): Succinate dehydrogenase
Genes: SDHD
Study 25097199 — Predictive Biomarker (PRD): CD34 mRNA
Genes: CD34
Study 25097199 — Safety Biomarker (SAF): B-type natriuretic peptide
Genes: NPPB
Study 25098565 — Pharmacodynamic Biomarker (PDY): Gastric inhibitory polypeptide
Genes: GIP
Study 25098565 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 25102193 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study 25102193 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study 25103305 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study 25104797 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 25105369 — Predictive Biomarker (PRD): O-6-methylguanine-DNA-alkyltransferase
Genes: MGMT
Study 25105826 — Predictive Biomarker (PRD): CFH mRNA
Genes: CFH; HF; HF1; HF2
Study 25105850 — Predictive Biomarker (PRD): DAP mRNA
Genes: DAP; DAP1
Study 25112732 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): Neutrophil gelatinase-associated lipocalin
Genes: LCN2; HNL; NGAL
Study 25113573 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study 25114718 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study 25114718 — Surrogate Endpoint (SUR): Blood pressure
Study 25115686 — Predictive Biomarker (PRD): SHBG mRNA
Genes: SHBG
Study 25116755 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study 25116755 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study 25122609 — Predictive Biomarker (PRD): SPHK2 mRNA
Genes: SPHK2; SK2
Study 25123851 — Surrogate Endpoint (SUR): Serum testosterone
Study 25129345 — Predictive Biomarker (PRD): BRCA1 mRNA
Genes: BRCA1; RNF53
Study 25129345 — Predictive Biomarker (PRD): Hormone receptor
Study 25130947 — Surrogate Endpoint (SUR): Blood pressure
Study 25131866 — Predictive Biomarker (PRD): AR mRNA
Genes: AR; DHTR; NR3C4
Study 25131866 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study 25133198 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 25133198 — Predictive Biomarker (PRD): CD14 mRNA
Genes: CD14
Study 25133198 — Predictive Biomarker (PRD): TLR2 mRNA
Genes: TLR2; TIL4
Study 25133198 — Predictive Biomarker (PRD): TLR4 mRNA
Genes: TLR4
Study 25134640 — Predictive Biomarker (PRD): DNAH5 mRNA
Genes: DNAH5; DNAHC5; HL1; KIAA1603
Study 25135992 — Predictive Biomarker (PRD): Leukocyte surface antigen Leu-16
Genes: MS4A1; CD20
Study 25135998 — Predictive Biomarker (PRD): Lymphocyte activation antigen CD30
Genes: TNFRSF8; CD30; D1S166E
Study 25136079 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study 25136079 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study 25136536 — Surrogate Endpoint (SUR): Blood pressure
Study 25136689 — Safety Biomarker (SAF): Hyaluronic acid
Study 25137424 — Predictive Biomarker (PRD): HSD3B2 mRNA
Genes: HSD3B2; HSDB3B
Study 25137424 — Predictive Biomarker (PRD); Safety Biomarker (SAF): CYP11A1 mRNA
Genes: CYP11A1; CYP11A
Study 25137427 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 25137427 — Surrogate Endpoint (SUR): Blood pressure
Study 25139018 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 25139963 — Predictive Biomarker (PRD): IFNL3 mRNA
Genes: IFNL3; IL28B; IL28C; ZCYTO22
Study 25139963 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 25141112 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Serum albumin
Genes: ALB; GIG20; GIG42; PRO0903; PRO1708; PRO2044; PRO2619; PRO2675; UNQ696/PRO1341
Study 25141237 — Pharmacodynamic Biomarker (PDY): Gastric inhibitory polypeptide
Genes: GIP
Study 25141237 — Predictive Biomarker (PRD): PYY mRNA
Genes: PYY
Study 25141237 — Pharmacodynamic Biomarker (PDY): Superoxide dismutase Cu-Zn
Genes: SOD1
Study 25142258 — Predictive Biomarker (PRD): CD70 mRNA
Genes: CD70; CD27L; CD27LG; TNFSF7
Study 25142320 — Predictive Biomarker (PRD): RBP4 mRNA
Genes: RBP4; PRO2222
Study 25142486 — Predictive Biomarker (PRD): Exhaled nitric oxide
Study 25142770 — Surrogate Endpoint (SUR): Blood pressure
Study 25144126 — Surrogate Endpoint (SUR): Blood pressure
Study 25148012 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study 25149761 — Predictive Biomarker (PRD): TLR2
Genes: TIL4; CD282
Study 25150798 — Pharmacodynamic Biomarker (PDY): Tyrosine-protein kinase BTK
Genes: BTK; AGMX1; ATK; BPK
Study 25150798 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Cellular tumor antigen p53
Genes: TP53; P53
Study 25151571 — Surrogate Endpoint (SUR): Serum sodium
Study 25152984 — Predictive Biomarker (PRD): APC mRNA
Genes: APC; DP2.5
Study 25152984 — Predictive Biomarker (PRD): TP73 mRNA
Genes: TP73; P73
Study 25152984 — Predictive Biomarker (PRD): DAPK1 mRNA
Genes: DAPK1; DAPK
Study 25154699 — Predictive Biomarker (PRD): FAM13A mRNA
Genes: FAM13A; FAM13A1; KIAA0914
Study 25154699 — Predictive Biomarker (PRD): BICD1 mRNA
Genes: BICD1
Study 25154699 — Predictive Biomarker (PRD): HHIP mRNA
Genes: HHIP; HIP; UNQ5825/PRO19644
Study 25154699 — Predictive Biomarker (PRD): CHRNA3 mRNA
Genes: CHRNA3; NACHRA3
Study 25154820 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study 25155085 — Predictive Biomarker (PRD): TBX21 mRNA
Genes: TBX21; TBET; TBLYM
Study 25155085 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 10
Genes: IL10
Study 25155085 — Predictive Biomarker (PRD): Interleukin 5
Genes: IL5
Study 25157214 — Pharmacodynamic Biomarker (PDY): Transmembrane glycoprotein NMB
Genes: GPNMB; HGFIN; NMB; UNQ1725/PRO9925
Study 25159833 — Surrogate Endpoint (SUR): Blood pressure
Study 25162366 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 25162465 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 25162522 — Predictive Biomarker (PRD): Vitamin D-binding protein
Genes: GC
Study 25163590 — Predictive Biomarker (PRD): NPC1L1 mRNA
Genes: NPC1L1
Study 25163590 — Predictive Biomarker (PRD): ABCG8 mRNA
Genes: ABCG8
Study 25164437 — Predictive Biomarker (PRD); Safety Biomarker (SAF): TP53
Genes: p53; LFS1
Study 25164945 — Predictive Biomarker (PRD): IGF2R mRNA
Genes: IGF2R; MPRI
Study 25167216 — Predictive Biomarker (PRD): CXCL13 mRNA
Genes: CXCL13; BCA1; BLC; SCYB13
Study 25167216 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY): Interleukin 6 receptor alpha
Genes: IL6R
Study 25167216 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Intercellular adhesion molecule 1
Genes: ICAM1
Study 25168842 — Monitoring Biomarker (MOI): HBV DNA
Study 25170013 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study 25170123 — Predictive Biomarker (PRD): BCR mRNA
Genes: BCR; BCR1; D22S11
Study 25170123 — Pharmacodynamic Biomarker (PDY): Tyrosine-protein kinase ABL1
Genes: ABL1; ABL; JTK7
Study 25170123 — Predictive Biomarker (PRD); Safety Biomarker (SAF): White blood cell
Study 25173047 — Predictive Biomarker (PRD): EPHX2 mRNA
Genes: EPHX2
Study 25173458 — Predictive Biomarker (PRD): ADAM17 mRNA
Genes: ADAM17; CSVP; TACE
Study 25174587 — Predictive Biomarker (PRD): Myeloid cell surface antigen CD33
Genes: CD33; SIGLEC3
Study 25174587 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 25175864 — Predictive Biomarker (PRD): TLR4 mRNA
Genes: TLR4
Study 25180155 — Predictive Biomarker (PRD): JAK1 mRNA
Genes: JAK1; JAK1A; JAK1B
Study 25180155 — Predictive Biomarker (PRD): CSF3R mRNA
Genes: CSF3R; GCSFR
Study 25181387 — Pharmacodynamic Biomarker (PDY): Fibroblast growth factor 23
Genes: FGF23; HYPF; UNQ3027/PRO9828
Study 25181387 — Pharmacodynamic Biomarker (PDY): Serum phosphate
Study 25181387 — Surrogate Endpoint (SUR): Bone mineral density
Study 25181387 — Surrogate Endpoint (SUR): Serum alkaline phosphatase
Study 25187881 — Surrogate Endpoint (SUR): Forced vital capacity
Study 25187919 — Monitoring Biomarker (MOI): HBV DNA
Study 25190134 — Monitoring Biomarker (MOI): Procalcitonin
Study 25190134 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 25190134 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study 25190633 — Predictive Biomarker (PRD): SCT mRNA
Genes: SCT
Study 25190651 — Predictive Biomarker (PRD): RPE mRNA
Genes: RPE; HUSSY-17
Study 25191939 — Predictive Biomarker (PRD): AQP4 mRNA
Genes: AQP4
Study 25192373 — Predictive Biomarker (PRD): PTS mRNA
Genes: PTS
Study 25193672 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study 25193672 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study 25196123 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-C motif chemokine 2
Genes: CCL2; MCP1; SCYA2
Study 25197009 — Surrogate Endpoint (SUR): Bone mineral density
Study 25198021 — Predictive Biomarker (PRD): TLR2 mRNA
Genes: TLR2; TIL4
Study 25199997 — Predictive Biomarker (PRD): SLC5A2 mRNA
Genes: SLC5A2; SGLT2
Study 25200610 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study 25201318 — Predictive Biomarker (PRD): COMT mRNA
Genes: COMT
Study 25201318 — Predictive Biomarker (PRD): SLC6A3 mRNA
Genes: SLC6A3; DAT1
Study 25201318 — Predictive Biomarker (PRD): DRD4 mRNA
Genes: DRD4
Study 25204423 — Monitoring Biomarker (MOI): Cell-free DNA
Study 25204977 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study 25207162 — Surrogate Endpoint (SUR): Bone mineral density
Study 25209657 — Predictive Biomarker (PRD): MLH1 mRNA
Genes: MLH1; COCA2
Study 25209657 — Predictive Biomarker (PRD): DNA mismatch repair protein MSH2
Genes: MSH2
Study 25211055 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study 25211344 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 25213741 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 25214517 — Predictive Biomarker (PRD): BOC mRNA
Genes: BOC; UNQ604/PRO1190
Study 25214544 — Monitoring Biomarker (MOI): Carcinoembryonic antigen CEA
Genes: CEACAM5; CEA
Study 25214544 — Predictive Biomarker (PRD): Apolipoprotein E
Genes: APOE
Study 25214838 — Predictive Biomarker (PRD): FTO mRNA
Genes: FTO; KIAA1752
Study 25214838 — Predictive Biomarker (PRD): INSIG2 mRNA
Genes: INSIG2
Study 25214838 — Predictive Biomarker (PRD): FASN mRNA
Genes: FASN; FAS
Study 25214838 — Predictive Biomarker (PRD): NPC1 mRNA
Genes: NPC1
Study 25214838 — Predictive Biomarker (PRD): PTER mRNA
Genes: PTER
Study 25214838 — Predictive Biomarker (PRD): MAF mRNA
Genes: MAF
Study 25214838 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY): Platelet glycoprotein 4
Genes: CD36; GP3B; GP4
Study 25217392 — Predictive Biomarker (PRD): CDK5 mRNA
Genes: CDK5; CDKN5; PSSALRE
Study 25222119 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 25222841 — Predictive Biomarker (PRD): PBX1 mRNA
Genes: PBX1; PRL
Study 25223394 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 25223501 — Predictive Biomarker (PRD): NLRP3 mRNA
Genes: NLRP3; C1orf7; CIAS1; NALP3; PYPAF1
Study 25224267 — Predictive Biomarker (PRD): FCGR3B
Genes: CD16; CD16b; FcgammaRIIIb; FcRIIIb
Study 25225206 — Predictive Biomarker (PRD): ACE2 mRNA
Genes: ACE2; UNQ868/PRO1885
Study 25225206 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study 25225437 — Predictive Biomarker (PRD): Proto-oncogene c-Met
Genes: MET
Study 25225437 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor receptor 2
Genes: KDR; FLK1; VEGFR2
Study 25226293 — Predictive Biomarker (PRD): FGFR1 mRNA
Genes: FGFR1; BFGFR; CEK; FGFBR; FLG; FLT2; HBGFR
Study 25226293 — Predictive Biomarker (PRD): GNRHR mRNA
Genes: GNRHR; GRHR
Study 25226407 — Predictive Biomarker (PRD): MYLK3 mRNA
Genes: MYLK3; MLCK
Study 25226426 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study 25227179 — Predictive Biomarker (PRD): Apolipoprotein E
Genes: APOE
Study 25227476 — Predictive Biomarker (PRD): PPARA mRNA
Genes: PPARA; NR1C1; PPAR
Study 25228850 — Predictive Biomarker (PRD): TG mRNA
Genes: TG
Study 25229334 — Surrogate Endpoint (SUR): Serum creatinine
Study 25229334 — Predictive Biomarker (PRD); Safety Biomarker (SAF): White blood cell
Study 25229334 — Surrogate Endpoint (SUR): Serum sodium
Study 25231271 — Predictive Biomarker (PRD): FHL5 mRNA
Genes: FHL5; ACT
Study 25232828 — Predictive Biomarker (PRD): Thymidylate synthase 
Genes: TYMS; TS; OK/SW-cl.29
Study 25234930 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study 25234930 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study 25236917 — Pharmacodynamic Biomarker (PDY): Dipeptidyl peptidase 4
Genes: DPP4; ADCP2; CD26
Study 25239224 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study 25239224 — Predictive Biomarker (PRD); Safety Biomarker (SAF): PIK3CA
Genes: PI3K
Study 25239228 — Predictive Biomarker (PRD): FLT3 mRNA
Genes: FLT3; CD135; FLK2; STK1
Study 25239440 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 25239440 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 25240453 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 25240453 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 25240453 — Pharmacodynamic Biomarker (PDY): High density lipoprotein cholesterol
Study 25240540 — Predictive Biomarker (PRD); Safety Biomarker (SAF): DES mRNA
Genes: DES
Study 25241909 — Predictive Biomarker (PRD): FAM13A mRNA
Genes: FAM13A; FAM13A1; KIAA0914
Study 25241909 — Predictive Biomarker (PRD): CRACR2B mRNA
Genes: CRACR2B; EFCAB4A
Study 25241909 — Predictive Biomarker (PRD): AP2A2 mRNA
Genes: AP2A2; ADTAB; CLAPA2; HIP9; HYPJ; KIAA0899
Study 25241909 — Predictive Biomarker (PRD): ATF6 mRNA
Genes: ATF6
Study 25241933 — Monitoring Biomarker (MOI): Procalcitonin
Study 25242374 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study 25242417 — Predictive Biomarker (PRD): TBXT mRNA
Genes: TBXT; T
Study 25242890 — Predictive Biomarker (PRD): UCN3 mRNA
Genes: UCN3; SPC
Study 25243573 — Surrogate Endpoint (SUR): Blood pressure
Study 25245327 — Safety Biomarker (SAF): Interleukin 2
Genes: IL2
Study 25245624 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 25245629 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 25246084 — Predictive Biomarker (PRD): CS mRNA
Genes: CS
Study 25250055 — Predictive Biomarker (PRD): CCS mRNA
Genes: CCS
Study 25250715 — Predictive Biomarker (PRD): Thymidylate synthase 
Genes: TYMS; TS; OK/SW-cl.29
Study 25250715 — Predictive Biomarker (PRD): ABO mRNA
Genes: ABO
Study 25250715 — Predictive Biomarker (PRD): IL1R2 mRNA
Genes: IL1R2; IL1RB
Study 25250858 — Safety Biomarker (SAF): Interleukin 2
Genes: IL2
Study 25253674 — Pharmacodynamic Biomarker (PDY): Signal transducer and activator of transcription 3
Genes: STAT3; APRF
Study 25253674 — Predictive Biomarker (PRD): CD14 mRNA
Genes: CD14
Study 25253770 — Predictive Biomarker (PRD): KRAS mRNA
Genes: KRAS; KRAS2; RASK2
Study 25253770 — Predictive Biomarker (PRD): NRAS mRNA
Genes: NRAS; HRAS1
Study 25253770 — Predictive Biomarker (PRD): FLT3 mRNA
Genes: FLT3; CD135; FLK2; STK1
Study 25253770 — Predictive Biomarker (PRD): PTPN11 mRNA
Genes: PTPN11; PTP2C; SHPTP2
Study 25253770 — Safety Biomarker (SAF): RAS pathway
Study 25253883 — Predictive Biomarker (PRD): SYK mRNA
Genes: SYK
Study 25253883 — Predictive Biomarker (PRD): JAK1 mRNA
Genes: JAK1; JAK1A; JAK1B
Study 25253883 — Predictive Biomarker (PRD): JAK2 mRNA
Genes: JAK2
Study 25254070 — Predictive Biomarker (PRD): CAPS mRNA
Genes: CAPS
Study 25256186 — Predictive Biomarker (PRD): ARCN1 mRNA
Genes: ARCN1; COPD
Study 25257635 — Predictive Biomarker (PRD): PVR mRNA
Genes: PVR; PVS
Study 25258037 — Predictive Biomarker (PRD): PAG1 mRNA
Genes: PAG1; CBP; PAG
Study 25260365 — Predictive Biomarker (PRD): Hormone receptor
Study 25260365 — Predictive Biomarker (PRD): Estrogen receptor
Genes: ESR1; ESR; NR3A1
Study 25264305 — Predictive Biomarker (PRD): ROS1 mRNA
Genes: ROS1; MCF3; ROS
Study 25264305 — Predictive Biomarker (PRD): ALK tyrosine kinase receptor
Genes: ALK
Study 25264305 — Predictive Biomarker (PRD): Proto-oncogene c-Met
Genes: MET
Study 25264814 — Predictive Biomarker (PRD): GFAP mRNA
Genes: GFAP
Study 25264981 — Predictive Biomarker (PRD): Apolipoprotein E
Genes: APOE
Study 25264981 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Metalloproteinase inhibitor 1
Genes: TIMP1; CLGI; TIMP
Study 25267741 — Pharmacodynamic Biomarker (PDY): Transmembrane glycoprotein NMB
Genes: GPNMB; HGFIN; NMB; UNQ1725/PRO9925
Study 25267955 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 25268986 — Safety Biomarker (SAF): Cystatin C
Genes: CST3
Study 25269577 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): D-dimer
Study 25270430 — Predictive Biomarker (PRD): SREBF1 mRNA
Genes: SREBF1; BHLHD1; SREBP1
Study 25270908 — Predictive Biomarker (PRD): FLT3 mRNA
Genes: FLT3; CD135; FLK2; STK1
Study 25271871 — Predictive Biomarker (PRD): TYMS
Genes: Tsase; TMS; HsT422
Study 25273351 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study 25273351 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 25273351 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 25276415 — Surrogate Endpoint (SUR): Blood pressure
Study 25276665 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 25281031 — Predictive Biomarker (PRD): ATP7A mRNA
Genes: ATP7A; MC1; MNK
Study 25281400 — Predictive Biomarker (PRD): CYP3A4 mRNA
Genes: CYP3A4; CYP3A3
Study 25281436 — Predictive Biomarker (PRD): CS mRNA
Genes: CS
Study 25283266 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study 25283752 — Predictive Biomarker (PRD): MECP2 mRNA
Genes: MECP2
Study 25285006 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 25285126 — Predictive Biomarker (PRD): MCC mRNA
Genes: MCC
Study 25285269 — Predictive Biomarker (PRD): ARCN1 mRNA
Genes: ARCN1; COPD
Study 25286173 — Surrogate Endpoint (SUR): Blood pressure
Study 25287104 — Predictive Biomarker (PRD): PPT1 mRNA
Genes: PPT1; CLN1; PPT
Study 25287822 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study 25288018 — Predictive Biomarker (PRD): Leukocyte surface antigen Leu-16
Genes: MS4A1; CD20
Study 25288198 — Predictive Biomarker (PRD): MAGEC1 mRNA
Genes: MAGEC1
Study 25288198 — Predictive Biomarker (PRD): MAGEC2 mRNA
Genes: MAGEC2; HCA587; MAGEE1
Study 25288198 — Predictive Biomarker (PRD); Monitoring Biomarker (MOI): Mucin-1
Genes: MUC1; PUM
Study 25288198 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study 25290090 — Pharmacodynamic Biomarker (PDY): Tyrosine-protein kinase ABL1
Genes: ABL1; ABL; JTK7
Study 25293768 — Surrogate Endpoint (SUR): Platelet count response
Study 25293773 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study 25295432 — Pharmacodynamic Biomarker (PDY): Gastric inhibitory polypeptide
Genes: GIP
Study 25295432 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 25295432 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 25295432 — Safety Biomarker (SAF): Plasminogen activator inhibitor
Genes: SERPINE1; PAI1; PLANH1
Study 25295432 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study 25295500 — Predictive Biomarker (PRD): CD34 mRNA
Genes: CD34
Study 25295500 — Predictive Biomarker (PRD): LMO2 mRNA
Genes: LMO2; RBTN2; RBTNL1; RHOM2; TTG2
Study 25295500 — Predictive Biomarker (PRD): MECOM mRNA
Genes: MECOM; EVI1; MDS1; PRDM3